top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quantum-Si Incorporated - Class A Common Stock (NQ:QSI)

0.8554 -0.0426 (-4.74%)
Streaming Delayed Price Updated: 2:40 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quantum-Si Incorporated - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports Third Quarter 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports Second Quarter 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si’s Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports First Quarter 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si’s Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15
From Quantum-Si Incorporated
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page